Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)

NCT01821963 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Low referral rate due to new therapeutic options.

Conditions

Infection

Interventions

DRUG: Pegylated Interferon Alfa 2a
DRUG: Ribavirin
DRUG: Telaprevir

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]